USP25 and head and neck squamous cell carcinoma: The results revealed that overexpression of USP25 sensitized the HNSCC tumors to anti-PD-1 treatment and resulted in lower tumor weights, whereas the tumors in the control group did not respond well to immunotherapy (Fig. 7D, E).